GSK planning 1,200 job cuts in Belgium, says paper
GSK is said to be preparing to cut around 1,200 positions from its workforce in Belgium as part of a cost-saving programme launched by CEO Luke Miels.
Newsletters and Deep Dive digital magazine
GSK is said to be preparing to cut around 1,200 positions from its workforce in Belgium as part of a cost-saving programme launched by CEO Luke Miels.
While the volume of announcements hit a mid-year slump, July and August still produced an exciting array of updates across the drug development arena.
Zealand has added another strand to its programme of weight-loss drug development, linking with AI player Generate on multispecific protein therapies.
BioNTech's vaccine for head and neck cancer has failed a clinical trial, but it will wait for more data before deciding the programme's fate.
Roche has added to its weight-loss drug pipeline again, turning to China's Rona Therapeutics for an RNAi candidate targeting ALK7.
Editor's Picks
Newsletters and Deep Dive
digital magazine
Editor's Picks